Neurological and neurocognitive function of HIV-infected children commenced on antiretroviral therapy
Journal Article
2008
Permanent link to this Item
Authors
Journal Title
South African Journal of Child Health
Link to Journal
Journal ISSN
Volume Title
Publisher
Health & Medical Publishing Group
Publisher
University of Cape Town
Department
Series
Abstract
Aim: To describe neurological and neurocognitive deficits in HIV-infected children and the short-term effect of highly active antiretroviral therapy (HAART) on the observed deficits. Methods: In this prospective study, 39 children (15 females) were evaluated before the start of HAART and 30 reassessed 6 months later. The subjects were evaluated with a range of cognitive tests used in everyday clinical practice. Results: At enrolment, the mean (±SD) age was 60±46 months, 17 (44%) and 22 (56%) had Centers for Disease Control (CDC) clinical category B and C disease respectively, and 36 (92%) had severe immunosuppression. At the start of HAART no child had cranial nerve or cerebellar dysfunction, but 13/29 (33.3%) had evidence of motor dysfunction. By 6 months 1 child had developed cerebellar dysfunction, but there was no statistically significant change in the frequency of motor dysfunction. Mean baseline performances on cognitive testing were generally subnormal. Between 33% and 81% of the children recorded subnormal intelligence quotients on various cognitive tests. Mean performances did not change significantly after 6 months of HAART. Conclusion: Neurological and neurocognitive deficits are frequent in HIV-infected children. The prevalence and extent of deficits did not change significantly in response to short-term HAART, indicating neither spontaneous improvement nor deterioration during early treatment.
Description
Reference:
Smith, L., Adnams, C., Eley, B. 2008. Neurological and neurocognitive function of HIV-infected children commenced on antiretroviral therapy. South African Journal of Child Health.